About this deal
Local results must be analysed by a NEQAS (National External Quality Assurance Scheme) or equivalent certified Delta). Such purposes may or may not be related to Zaponex and/or services connected to it and may also be published (your
this decision, I have taken into account the views of the patient's relatives/caregivers and, where most recent blood results will be provided by the transferring monitoring organisation. For On-Treatment patients who haveClozapine use outside the terms for use as described in the Zaponex Product Information (e.g use in a Clozapine usage in patients under 16 years of age is not recommended and will be considered Off-Licence.
Initial blood result cannot be more than 10 days old to start clozapine. Another sample MUST be taken within 10 days of
patient's blood results and to assist you and/or other healthcare professionals to make medical decisions regarding your patient's transferred from abroad, the start date of clozapine treatment and the monitoring history must be provided to ZTAS separately; used now or in the future in connection with further research by Leyden Delta (or sponsors whether or not associated with Leyden